Stryker Corp
NYSE:SYK
Stryker Corp
Accrued Liabilities
Stryker Corp
Accrued Liabilities Peer Comparison
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Stryker Corp
NYSE:SYK
|
Accrued Liabilities
$2.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
NYSE:BSX
|
Accrued Liabilities
$2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Accrued Liabilities
$24.8m
|
CAGR 3-Years
-64%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
|
Abbott Laboratories
NYSE:ABT
|
Accrued Liabilities
$6.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accrued Liabilities
$691.4m
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
15%
|
See Also
What is Stryker Corp's Accrued Liabilities?
Accrued Liabilities
2.9B
USD
Based on the financial report for Mar 31, 2024, Stryker Corp's Accrued Liabilities amounts to 2.9B USD.
What is Stryker Corp's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
3%
Over the last year, the Accrued Liabilities growth was 10%. The average annual Accrued Liabilities growth rates for Stryker Corp have been 3% over the past three years , 6% over the past five years , and 3% over the past ten years .